机构:[1]Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China,神经科系统神经内科首都医科大学宣武医院[2]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China,[3]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China[4]Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China[5]Department of Nuclear Medicine, China-Japan Friendship Hospital, Beijing, China[6]Department of Nuclear Medicine, The First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing, China[7]Center for Cognitive Disorders, Beijing Geriatric Hospital, Beijing, China
the National Key R&D Program
of China (No. 2017YFC1310103), Capital’s Funds for Health
Improvement and Research (CFH2020-4-1033), Beijing
Municipal Administration of Hospitals Clinical Medicine
Development of Special Funding Support (No. ZYLX201837),
National Key R&D Program (2016YFC1306305), and Beijing
Municipal Natural Science Foundation (No. 7192192).
第一作者机构:[1]Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China,[2]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China,[3]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China[4]Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
共同第一作者:
通讯作者:
通讯机构:[1]Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China,[2]Center of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China,[3]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China[4]Neurodegenerative Laboratory of Ministry of Education of the People’s Republic of China, Beijing, China
推荐引用方式(GB/T 7714):
Qi Qin,Liping Fu,Ruimin Wang,et al.Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study.[J].FRONTIERS IN AGING NEUROSCIENCE.2021,13:doi:10.3389/fnagi.2021.732159.
APA:
Qi Qin,Liping Fu,Ruimin Wang,Jihui Lyu,Huixuan Ma...&Cuibai Wei.(2021).Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study..FRONTIERS IN AGING NEUROSCIENCE,13,
MLA:
Qi Qin,et al."Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study.".FRONTIERS IN AGING NEUROSCIENCE 13.(2021)